Clinical Trials Directory

Trials / Conditions / Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)

8 registered clinical trials studyying Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
NCT06798012
TakedaPhase 2
RecruitingA Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
NCT06747351
TakedaPhase 3
RecruitingA Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine C
NCT06538064
Takeda—
CompletedA Safety Study of GAMMAGARD LIQUID (GGL) in Participants With Chronic Inflammatory Demyelinating Polyradiculon
NCT05363358
Takeda—
Active Not RecruitingA Study of TAK-771 in Japanese Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CI
NCT05084053
TakedaPhase 3
CompletedA Study to Assess Long-term Safety, Tolerability and Efficacy of Rozanolixizumab in Subjects With Chronic Infl
NCT04051944
UCB Biopharma SRLPhase 2
CompletedThe Evaluation of Efficacy and Safety of Rituximab in Refractory CIDP Patients With IgG4 Autoantibodies
NCT03864185
Nagoya UniversityPhase 2
CompletedA Study to Assess the Efficacy, Safety and Tolerability of Rozanolixizumab in Subjects With Chronic Inflammato
NCT03861481
UCB Biopharma S.P.R.L.Phase 2